antipsychotics
-
5-HT7, acute psychosis, antipsychotics, d2 receptor, Drugs, JEWEL trial, lurasidone, negative symptoms, Neurotransmitters, PANSS, positive symptoms, Psychiatry, psychosis, schizophreniaLurasidone Improves Positive Symptoms of Schizophrenia More Than Negative
Lurasidone is approved for schizophrenia and bipolar depression on the strength of…
-
agitation, antipsychotics, atypical antipsychotics, cardiovascular disease, CPRD, Dementia, Drugs, FDA black-box warning, matched cohort study, Neurodegenerative Diseases, older adults, Psychiatry, risperidone, side effects, strokeRisperidone Stroke Risk in Dementia: HR 1.28 Across CVD Subgroups
The risperidone-stroke link in dementia is one of the longest-running safety signals…
-
antipsychotics, British Journal of Psychiatry, cardiometabolic risk, causal inference, comorbidities, comorbidity, early intervention, Editor Eimear Foley, first episode psychosis, haloperidol, mediation analysis, metabolic health, mortality gap, obesity, olanzapine, personalised medicine, physical health inequalities, precision psychiatry, prediction modelling, psychosis, randomised controlled trial, schizophrenia, side effects, topical, weight gainCan we predict and prevent weight gain in early psychosis?
On average, people with psychosis die 15 years earlier than the general…
-
#UCLJournalClub, antipsychotic discontinuation, antipsychotics, dose reduction, Editor Dafni Katsampa, first episode psychosis, JAMA Psychiatry, NICE guidelines, psychosis, randomised controlled trial, schizophrenia, secondary care, topical, UCL Division of PsychiatryStop, reduce or stay on antipsychotics after first-episode psychosis?
Recovery from first-episode psychosis (FEP) often brings a sense of relief, but…
